Cvs Health CORP Form 4 insider transactions
NYSE
CVS Health EVP Steven H. Nelson reported an indirect purchase of 24 common shares via a trust, correcting a prior broker error.
NYSE
CVS Health EVP and Group President Prem S. Shah disposed of 247 common shares to cover tax obligations related to deferred stock unit settlement.
NYSE
CVS Health Corp's SVP, Controller & Chief Accounting Officer, James David Clark, disposed of 220 restricted common shares to cover FICA tax obligations.
NYSE
CVS Health Corp's EVP, Chief Experience & Technology Officer, Tilak Mandadi, disposed of 6,575 shares to cover tax withholding on a restricted stock unit award.
NYSE
CVS Health Director Roger N. Farah reported the disposition of 9,748 common shares to cover tax obligations related to a restricted stock unit award.
NYSE
CVS Health's EVP and Chief People Officer, Heidi B. Capozzi, disposed of 9,470 shares of common stock to cover tax withholdings from a restricted stock unit award.
NYSE
CVS Health Director Douglas H. Shulman acquired 1,652 shares of common stock as part of his semi-annual retainer, valued at $76.04 per share.
NYSE
CVS Health Director Guy P. Sansone acquired 1,652 shares of common stock at $76.04 per share as part of his semi-annual retainer.
NYSE
CVS Health Director Larry Robbins acquired 2,202.788 deferred stock units as part of his compensation plan.
NYSE
CVS Health Director Leslie V. Norwalk acquired 1,652 shares of common stock valued at $125,626.08 as part of a semi-annual retainer.
NYSE
CVS Health Director Michael F. Mahoney acquired 2,021.9621 deferred stock units as part of his compensation plan.
NYSE
CVS Health Corp. Director J. Scott Kirby acquired 1,652 shares of common stock as part of a semi-annual retainer payment.
NYSE
CVS Health Director Anne Finucane acquired additional common stock and deferred stock units on November 20, 2025, as part of her routine compensation package.
NYSE
CVS Health Corp. Director Alecia A. DeCoudreaux acquired 1,652.091 deferred stock units as part of her compensation plan.
NYSE
CVS Health Corp. Director C. David Brown II acquired 1,775 shares of common stock at $76.04 per share as part of his semi-annual retainer.
NYSE
CVS Health Director Jeffrey R. Balser acquired 1,775 shares of common stock as part of his semi-annual retainer, increasing his beneficial ownership.
NYSE
CVS Health Corp. Director Fernando Aguirre acquired 1,800 shares of common stock at $76.04 per share, totaling $136,872, as part of a semi-annual retainer.
NYSE
CVS Health's EVP and Chief People Officer, Heidi B. Capozzi, reported indirect purchases of company common stock totaling 80 shares through a trust, correcting a prior broker error.
NYSE
CVS Health EVP Prem S. Shah disposed of 6,995 shares of common stock to cover tax withholdings from a restricted stock unit award.
NYSE
CVS Health EVP Tilak Mandadi disposed of 12,834 common shares to cover tax withholdings from restricted stock unit vesting.
NYSE
CVS Health Director Anne A. Finucane reported the sale of 7,500 shares of common stock for $71.02 per share, a transaction that was not timely reported due to an administrative error.
NYSE
CVS Health Corp. Director Guy P. Sansone acquired 1,570 shares of common stock, increasing his direct beneficial ownership in the company.
NYSE
CVS Health's Executive Vice President and Chief Financial Officer, Brian Newman, was granted 21,861 restricted stock units and 94,786 stock options on May 31, 2025, as part of the company's incentive compensation plan.
NYSE
CVS Health's EVP and Chief Medical Officer, Amy Compton-Phillips, has been granted 53,091 restricted stock units and 27,081 stock options, aligning her incentives with shareholder value.
NYSE
Director Douglas Shulman acquired 2,077 shares of CVS Health Corp common stock as part of a semi-annual retainer under the 2017 Incentive Compensation Plan.
NYSE
Guy P. Sansone, a director of CVS Health Corp, acquired 2,077 shares of common stock as part of the company's incentive compensation plan.
NYSE
Director Larry Robbins reports acquisition of deferred stock units in CVS Health Corp.
NYSE
Director Leslie V. Norwalk acquired 2,077 shares of CVS Health Corp common stock as part of a semi-annual retainer under the company's 2017 Incentive Compensation Plan.
NYSE
Form 4: CVS Health Director Michael Mahoney Reports Acquisition of Common Stock and Deferred Stock Units
Director Michael Mahoney reports acquisition of CVS Health common stock and deferred stock units related to director compensation.
NYSE
Director J Scott Kirby acquired 2,769 shares of CVS Health Corp common stock as part of a semi-annual retainer under the 2017 Incentive Compensation Plan.